UK markets closed
NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,284.54 +83.27 (+0.48%) CRUDE OIL
83.76 +0.95 (+1.15%) GOLD FUTURES
2,344.20 +5.80 (+0.25%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,825.61 +643.25 (+1.26%)
AstraZeneca PLC (AZN.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 05:15PM BST
| Previous close | 11,352.00 |
| Open | 11,890.00 |
| Bid | 11,054.00 x 0 |
| Ask | 12,100.00 x 0 |
| Day's range | 11,790.00 - 12,096.00 |
| 52-week range | 9,461.00 - 12,186.00 |
| Volume | |
| Avg. volume | 2,911,904 |
| Market cap | 186.429B |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 39.17 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.28 (2.01%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | N/A |
- Yahoo Finance
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
- Investor's Business Daily
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.
- Zacks
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease drugs.
© 2024 Yahoo. All rights reserved.